The Workshop will address the clinical potential of radiotheranostics in cancer diagnosis and treatment, focusing on the examples of neuroendocrine tumours and advanced prostate cancer, two indications for which now approved radiopharmaceuticals exist. The workshop attempts to identify obstacles for a broader use of such radiopharmaceuticals in clinical practice and discusses possible ways to overcome them.
Cuándo: 27 de abril a las 8:30 horas.
Dónde: Joint Research Centre, Ispra, Italy
Idioma: English
Precio: free of charge, but no reimbursement for travel and hotel costs is granted.
Fecha inscripción: the deadline for registration is 31st March 2023.
Cómo participar:
Should you be interested in participating, please contact the meeting assistants at JRC-F2-MEETINGS@ec.europa.eu for further information and details on the registration procedure, indicating whether you have a preference to attend on-site in Ispra or remotely via Webex.
Please note that for the attendance on site only a limited hotel capacity is available and the requests are processed on a first come, first served basis.
